Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yaomin Xu

Showing results (51-60 of 85) with videos related to

Pageof 9
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 9, 2022
Immunostimulatory Cancer-Associated Fibroblast Subpopulations Can Predict Immunotherapy Response in Head and Neck CancerAleksandar Obradovic, Diana Graves, Michael Korrer, et al.
JAMA Dermatology|February 26, 2025
Risk of Major Adverse Cardiovascular Events Following Nicotinamide ExposureLee Wheless, Ranya Guennoun, Basia Michalski-McNeely, et al.
Medrxiv : the Preprint Server for Health Sciences|October 7, 2024
No Increased Risk of Major Adverse Cardiovascular Events following Nicotinamide ExposureLee Wheless, Ranya Guennoun, Basia Michalski-McNeely, et al.
Research Square|July 17, 2025
Peripheral blood gene expression signatures of systemic immunity predict tumor microenvironment biology and therapeutic response in breast cancerJustin Balko, Xiaopeng Sun, Ann Hanna, et al.
Blood|January 18, 2023
A practical approach to curate clonal hematopoiesis of indeterminate potential in human genetic data setsCaitlyn Vlasschaert, Taralynn Mack, J Brett Heimlich, et al.
The Journal of Molecular Diagnostics : JMD|April 8, 2024
Cost-Effective and Scalable Clonal Hematopoiesis Assay Provides Insight into Clonal DynamicsTaralynn Mack, Caitlyn Vlasschaert, Kelly von Beck, et al.
Medrxiv : the Preprint Server for Health Sciences|November 21, 2023
Cost-effective and scalable clonal hematopoiesis assay provides insight into clonal dynamicsTaralynn Mack, Caitlyn Vlasschaert, Kelly von Beck, et al.
NPJ Breast Cancer|May 16, 2018
Phase II study of ruxolitinib, a selective JAK1/2 inhibitor, in patients with metastatic triple-negative breast cancerDaniel G Stover, Carlos R Gil Del Alcazar, Jane Brock, et al.
Anaerobe|January 26, 2023
Walk before you run: Feasibility challenges and lessons learned from the PROCLAIM study, a multicenter randomized controlled trial of misoprostol for prevention of recurrent Clostridioides difficile during COVID-19Robert R Lavieri, Erik R Dubberke, Sarah K McGill, et al.
Medrxiv : the Preprint Server for Health Sciences|March 17, 2025
Genetic drivers and clinical consequences of mosaic chromosomal alterations in 1 million individualsKun Zhao, Yash Pershad, Hannah M Poisner, et al.
Pageof 9

Showing results (51-60 of 85) with videos related to

Sort By:
Pageof 9
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 9, 2022
Immunostimulatory Cancer-Associated Fibroblast Subpopulations Can Predict Immunotherapy Response in Head and Neck CancerAleksandar Obradovic, Diana Graves, Michael Korrer, et al.
JAMA Dermatology|February 26, 2025
Risk of Major Adverse Cardiovascular Events Following Nicotinamide ExposureLee Wheless, Ranya Guennoun, Basia Michalski-McNeely, et al.
Medrxiv : the Preprint Server for Health Sciences|October 7, 2024
No Increased Risk of Major Adverse Cardiovascular Events following Nicotinamide ExposureLee Wheless, Ranya Guennoun, Basia Michalski-McNeely, et al.
Research Square|July 17, 2025
Peripheral blood gene expression signatures of systemic immunity predict tumor microenvironment biology and therapeutic response in breast cancerJustin Balko, Xiaopeng Sun, Ann Hanna, et al.
Blood|January 18, 2023
A practical approach to curate clonal hematopoiesis of indeterminate potential in human genetic data setsCaitlyn Vlasschaert, Taralynn Mack, J Brett Heimlich, et al.
The Journal of Molecular Diagnostics : JMD|April 8, 2024
Cost-Effective and Scalable Clonal Hematopoiesis Assay Provides Insight into Clonal DynamicsTaralynn Mack, Caitlyn Vlasschaert, Kelly von Beck, et al.
Medrxiv : the Preprint Server for Health Sciences|November 21, 2023
Cost-effective and scalable clonal hematopoiesis assay provides insight into clonal dynamicsTaralynn Mack, Caitlyn Vlasschaert, Kelly von Beck, et al.
NPJ Breast Cancer|May 16, 2018
Phase II study of ruxolitinib, a selective JAK1/2 inhibitor, in patients with metastatic triple-negative breast cancerDaniel G Stover, Carlos R Gil Del Alcazar, Jane Brock, et al.
Anaerobe|January 26, 2023
Walk before you run: Feasibility challenges and lessons learned from the PROCLAIM study, a multicenter randomized controlled trial of misoprostol for prevention of recurrent Clostridioides difficile during COVID-19Robert R Lavieri, Erik R Dubberke, Sarah K McGill, et al.
Medrxiv : the Preprint Server for Health Sciences|March 17, 2025
Genetic drivers and clinical consequences of mosaic chromosomal alterations in 1 million individualsKun Zhao, Yash Pershad, Hannah M Poisner, et al.
Pageof 9